Since knockdown of ITGAV and to a lesser extent treatment with the GLPG0187 compound in UM-UC-3 and RT-4 cells resulted in a significant decrease in SNAI2, SNAI2 might play an important role in EMT in bladder cancer. This evidence concerns the gene ITGAV and urinary bladder cancer.